Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 23 Jul 2024

40 mn people living with HIV in 2023, over 9 mn not getting treatment: UN

Business Standard

Nearly 40 million people were living with the HIV virus that causes AIDS last year, over 9 million weren't getting any treatment, and the result was that every minute someone died of AIDS-related causes, the UN said in a new report launched Monday. While advances are being made to end the global AIDS pandemic, the report said progress has slowed, funding is shrinking, and new infections are rising in three regions: the Middle East and North Africa, Eastern Europe and Central Asia, and Latin America. In 2023, around 6,30,000 people died from AIDS-related illnesses, a significant decline from the 2.1 million deaths in 2004. But the latest figure is more than double the target for 2025 of fewer than 2,50,000 deaths, according to the report by UNAIDS, the UN agency leading the global effort to end the pandemic. Gender inequality is exacerbating the risks for girls and women, the report said, citing the extraordinarily high incidence of HIV among adolescents and young women in parts of .

Pharmaceuticals & Biotech.

SECTOR | 22 Jul 2024

Pharma sector shows resilience: Bulk drug exports surge, import dependency tackled with PLI boost

Business Line

India's import dependency of APIs are largely due to a lack of cost-effective options in domestic API manufacturing compared with imports, the Survey noted

Pharmaceuticals & Biotech.

SECTOR | 19 Jul 2024

Medical devices platform seeks measures in Budget to reduce reliance on imports

Business Line

AIMED, in its pre-budget submission, called for a 10 to 15 per cent hike in customs duty on certain items.

Pharmaceuticals & Biotech.

SECTOR | 17 Jul 2024

Pharma companies on track with QR codes to combat counterfeit drugs

Business Standard

The pharma industry has welcomed the DCGI mandate as they view it as a positive step to combat counterfeit drugs and ensure patient safety

Pharmaceuticals & Biotech.

SECTOR | 15 Jul 2024

Healtcare Q1 Results Preview - FY25 To Start On A Positive Note: ICICI Securities

NDTV Profit

Hospitals are likely to report revenue/Ebitda/profit after tax growth of 13%/29%/45% YoY in Q1, says the brokerage

Pharmaceuticals & Biotech.

SECTOR | 10 Jul 2024

Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?

Business Standard

According to analysts, Emcure Pharma is quoting at a reasonable valuation with a niche opportunity to invest in the gynaecology and HIV antivirals therapeutic areas

Pharmaceuticals & Biotech.

SECTOR | 01 Jul 2024

Teva Pharmaceutical To Face FTC Investigation Over Patents

NDTV Profit

Teva Pharmaceutical Industries Ltd. is being investigated by the US Federal Trade Commission over patents for certain drugs including asthma inhalers, according to a person familiar with the matter.